logo
Plus   Neg
Share
Email

Nissan November Global Vehicle Sales Down 10.3%

Nissan Motor Co., Ltd. reported that global sales for the month of November 2019 declined 10.3 percent to 417,913 vehicles from a year earlier. Global production for the month also decreased 14.1 percent year-over-year to 427,948 vehicles.

Monthly vehicle productions in Japan were 65,092 units, down 17.8 percent from the previous year. Sales including Minivehicles in Japan declined 16.7 percent to 37,992 units from a year earlier.

Earlier today, Nissan said that its executive officer and vice chief operating officer Jun Seki has decided to step down from his position.

Jun Seki reportedly plans to join the Japanese manufacturer Nidec Corp. as president and chief operating officer.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Novacyt S.A. said it is seeing unprecedented demand for the novel coronavirus or COVID-19 diagnostic test kit developed by Primerdesign, the company's molecular diagnostics division based in the UK. As of March 27, Primerdesign has sold and received orders for more than 17.8 million pounds of its CE-Mark COVID-19 tests. Novacyt is currently selling its COVID-19 test to more than 80 countries. The U.S. Food and Drug Administration has issued an Emergency Use Authorization to allow anti-malaria drugs hydroxychloroquine sulfate and chloroquine phosphate donated to the Strategic National Stockpile as possible treatments for coronavirus (COVID-19) patients. This is the first EUA for a drug related to the COVID-19 response. Gilead Sciences Inc. said it is transitioning to "expanded access programs" from "compassionate use" programs for its experimental anti-coronavirus drug, remdesivir. The company noted that the expanded access will allow hospitals or physicians to apply for emergency use of remdesivir for multiple severely ill patients at one time, as they struggle to deal with the COVID-19 or coronavirus pandemic.
Follow RTT
>